(1) Net income and net income per share include purchased research and development expenses of $508.4 million and realized gains on the sale of a minority stock investment of $152.7 million. Pro forma net income and net income per share, excluding these nonrecurring items net of tax, would have been $1,413,893 and $2.05, respectively.

(2) Net income and net income per share include purchased research and development expenses of $95.8 million. Pro forma net income and net income per share, excluding these nonrecurring items net of tax, would have been $515,723 and $0.82, respectively.